miltirone has been researched along with tanshinone ii a in 4 studies
| Studies (miltirone) | Trials (miltirone) | Recent Studies (post-2010) (miltirone) | Studies (tanshinone ii a) | Trials (tanshinone ii a) | Recent Studies (post-2010) (tanshinone ii a) |
|---|---|---|---|---|---|
| 31 | 0 | 25 | 61 | 0 | 41 |
| Protein | Taxonomy | miltirone (IC50) | tanshinone ii a (IC50) |
|---|---|---|---|
| Chain A, RNA-directed RNA polymerase NS5 | Dengue virus 2 16681-PDK53 | 100 | |
| Apoptotic peptidase activating factor 1 | Homo sapiens (human) | 4.82 | |
| Spike glycoprotein | Betacoronavirus England 1 | 0.8 | |
| Replicase polyprotein 1ab | Betacoronavirus England 1 | 0.8 | |
| caspase-9 isoform alpha precursor | Homo sapiens (human) | 11.2 | |
| caspase-3 isoform a preproprotein | Homo sapiens (human) | 11.2 | |
| Telomerase reverse transcriptase | Homo sapiens (human) | 2.75 | |
| Transmembrane protease serine 2 | Homo sapiens (human) | 0.8 | |
| Procathepsin L | Homo sapiens (human) | 0.8 | |
| Aldo-keto reductase family 1 member B1 | Rattus norvegicus (Norway rat) | 1.14 | |
| Replicase polyprotein 1a | Severe acute respiratory syndrome-related coronavirus | 1.2 | |
| Replicase polyprotein 1ab | Human coronavirus 229E | 0.8 | |
| Replicase polyprotein 1ab | Severe acute respiratory syndrome-related coronavirus | 0.8 | |
| Replicase polyprotein 1ab | Severe acute respiratory syndrome coronavirus 2 | 1.1855 | |
| Aldo-keto reductase family 1 member B1 | Homo sapiens (human) | 8.69 | |
| Tyrosine-protein phosphatase non-receptor type 6 | Homo sapiens (human) | 2.14 | |
| Spike glycoprotein | Severe acute respiratory syndrome-related coronavirus | 0.8 | |
| Tyrosine-protein phosphatase non-receptor type 11 | Homo sapiens (human) | 2.59 | |
| Hypoxia-inducible factor 1-alpha | Homo sapiens (human) | 6.855 | |
| Endothelial PAS domain-containing protein 1 | Homo sapiens (human) | 6.855 | |
| Angiotensin-converting enzyme 2 | Homo sapiens (human) | 0.8 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (75.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Adams, M; Fronza, M; Hamburger, M; Heinzmann, B; Laufer, S; Merfort, I; Murillo, R; Ślusarczyk, S | 1 |
| Jeong, HJ; Kim, DW; Kim, JH; Kim, YM; Kwon, HJ; Lee, WS; Park, JY; Park, KH; Park, SJ; Ryu, YB | 1 |
| Edwards, CC; Hatfield, MJ; Hyatt, JL; Jeffries, C; Lemoff, A; Potter, PM; Tsurkan, LG; Yan, B | 1 |
| Chen, J; Gao, K; Huang, F; Tepe, JJ; Wang, R; Wei, GW | 1 |
4 other study(ies) available for miltirone and tanshinone ii a
| Article | Year |
|---|---|
In vitro cytotoxic activity of abietane diterpenes from Peltodon longipes as well as Salvia miltiorrhiza and Salvia sahendica.
Topics: Abietanes; Antineoplastic Agents, Phytogenic; Cell Line, Tumor; Cytotoxins; Drug Screening Assays, Antitumor; Humans; Lamiaceae; Phytotherapy; Plant Extracts; Plant Roots; Salvia; Structure-Activity Relationship | 2011 |
Tanshinones as selective and slow-binding inhibitors for SARS-CoV cysteine proteases.
Topics: Abietanes; Cysteine Proteinase Inhibitors; Humans; Kinetics; Protein Binding; Salvia miltiorrhiza; Severe Acute Respiratory Syndrome; Severe acute respiratory syndrome-related coronavirus; Ubiquitination | 2012 |
Modulation of esterified drug metabolism by tanshinones from Salvia miltiorrhiza ("Danshen").
Topics: Abietanes; Algorithms; Camptothecin; Carboxylesterase; Clinical Trials, Phase I as Topic; Drugs, Chinese Herbal; Herb-Drug Interactions; Humans; Irinotecan; Medicine, Chinese Traditional; Molecular Structure; Phenanthrolines; Plant Roots; Salvia miltiorrhiza | 2013 |
Perspectives on SARS-CoV-2 Main Protease Inhibitors.
Topics: Antiviral Agents; Coronavirus 3C Proteases; Humans; Protease Inhibitors | 2021 |